AANPCB Board Prep/Care Practices
๐Ÿ“‹

Care Practices

Treatment planning, level of care decisions, safety planning, referrals, collaborative care, and special populations.

108 questions ยท AANPCB knowledge area

Practice Care Practices Questions

Build a custom quiz and track your performance across AANPCB knowledge areas and process domains.

Build a Quiz

All 108 questions

1.
Level of Care Criteria: Inpatient vs. Outpatient
beginnersuicide risk assessmentlevel of careinpatient
โ†’
2.
Collaborative Care Model Roles
intermediatecollaborative careCoCMintegrated care
โ†’
3.
Stepped Care Model for Depression
beginnerstepped caremild depressionPHQ-9
โ†’
4.
Collaborative Care: Treatment-to-Target Adjustment
intermediatecollaborative caretreat-to-targetcaseload review
โ†’
5.
Relapse Prevention Planning for Bipolar Disorder
intermediatebipolar disorderrelapse preventionlithium
โ†’
6.
Stanley-Brown Safety Planning Intervention
beginnersafety planningStanley-Brownsuicide prevention
โ†’
7.
Shared Decision-Making with Treatment-Resistant Depression
advancedshared decision-makingtreatment-resistant depressionpatient autonomy
โ†’
8.
Behavioral Interventions in Intellectual Disability
intermediateintellectual disabilityfunctional behavioral assessmentbehavioral interventions
โ†’
9.
Measurement-Based Care: Evidence for Implementation Over Clinical Judgment Alone
intermediatemeasurement-based carequality improvementPHQ-9
โ†’
10.
Treatment of Comorbid PTSD and Substance Use Disorder
intermediatePTSDsubstance use disorderintegrated treatment
โ†’
11.
Eating Disorder Level of Care: Medical Instability Criteria
intermediateanorexia nervosalevel of caremedical stabilization
โ†’
12.
Integrating Peer Support Specialists into Treatment Planning
beginnerpeer supportrecovery modelserious mental illness
โ†’
13.
Integrated vs. Sequential Treatment for Dual Diagnosis
intermediatedual diagnosisintegrated treatmentco-occurring disorders
โ†’
14.
Suicide Risk Stratification and Disposition Decision-Making
advancedsuicide risk stratificationdispositioninvoluntary admission
โ†’
15.
Step-Down from Inpatient to Partial Hospitalization: Transition Planning
intermediatepartial hospitalizationstep-down caredischarge planning
โ†’
16.
Homeless Population: Treatment Barriers and Adaptations
intermediatehomelessnessschizophreniaLAI antipsychotic
โ†’
17.
Incarcerated Patients: Psychiatric Care Considerations
advancedcorrectional psychiatryEstelle v. Gambleincarceration
โ†’
18.
Deaf and Hearing-Impaired Patients: Communication and Assessment
intermediateDeaf patientsASL interpreterADA
โ†’
19.
Stepped Care Model for Generalized Anxiety Disorder
beginnerstepped caregeneralized anxiety disorderGAD-7
โ†’
20.
Collaborative Care Model Integration for Depression
intermediatecollaborative care modelpsychiatric consultationmeasurement-based care
โ†’
21.
Using PHQ-9 and GAD-7 Thresholds for Treatment Decisions
beginnerPHQ-9GAD-7measurement-based care
โ†’
22.
Relapse Prevention Planning for Alcohol Use Disorder
intermediaterelapse preventionalcohol use disordersubstance use disorders
โ†’
23.
Treatment Planning for Comorbid PTSD and Substance Use
advancedPTSDsubstance use disordercomorbid treatment
โ†’
24.
Shared Decision-Making in Antipsychotic Selection
intermediateshared decision-makingantipsychoticshyperprolactinemia
โ†’
25.
Psychotropic Prescribing Principles in Intellectual Disability
advancedintellectual disabilitydiagnostic overshadowingpsychotropic prescribing
โ†’
26.
Medication Reconciliation During Transitions of Care
beginnermedication reconciliationtransitions of carepatient safety
โ†’
27.
Dementia Agitation โ€” Sundowning and Treatable Causes
intermediatedementiasundowningagitation
โ†’
28.
Valproate Teratogenicity and Neural Tube Defect Risk in Pregnancy
hardpregnancyvalproateteratogenicity
โ†’
29.
Geriatric Anticholinergic Burden and Beers Criteria Application
intermediategeriatricanticholinergic-burdenbeers-criteria
โ†’
30.
Pediatric SSRI Black Box Warning and Suicidality Monitoring
intermediatepediatricSSRIblack-box-warning
โ†’
31.
Postpartum Depression Screening with the Edinburgh Postnatal Depression Scale
intermediatepostpartum-depressionEPDSscreening
โ†’
32.
Psychotropic Use Considerations in Intellectual Disability
hardintellectual-disabilitydiagnostic-overshadowingself-injurious-behavior
โ†’
33.
Transgender Patient Psychiatric Assessment and Minority Stress
hardtransgenderminority-stressgender-identity
โ†’
34.
Differentiating Delirium from Dementia in Geriatric Patients
intermediategeriatricdeliriumdementia
โ†’
35.
Medical Complications of Adolescent Eating Disorders and Refeeding Risk
hardeating-disordersanorexia-nervosarefeeding-syndrome
โ†’
36.
Perinatal Anxiety Management and Breastfeeding Medication Safety
intermediateperinatalbreastfeedinganxiety
โ†’
37.
Autism Spectrum Disorder and Co-occurring Psychiatric Conditions
hardautism-spectrum-disorderdepressiondiagnostic-overshadowing
โ†’
38.
Military/Veteran PTSD and Cultural Barriers to Treatment
intermediateveteransPTSDmilitary-culture
โ†’
39.
Geriatric Polypharmacy, Psychotropic Medications, and Fall Risk
intermediategeriatricpolypharmacyfall-risk
โ†’
40.
Assessing Treatment Adherence Barriers
hardadherencelamotriginebipolar disorder
โ†’
41.
Measuring Functional Improvement vs Symptom Reduction
intermediatefunctional impairmentPHQ-9Sheehan Disability Scale
โ†’
42.
Assessing Treatment Response in Pediatric Anxiety
intermediatepediatric anxietySCAREDmulti-informant assessment
โ†’
43.
Assessing Quality of Life in Chronic Mental Illness
hardquality of lifeschizophreniarecovery-oriented care
โ†’
44.
Medication Interaction Assessment in Polypharmacy
hardpolypharmacydrug-interactionsCYP450
โ†’
45.
Comorbid PTSD and SUD Treatment Planning
hardPTSDsubstance use disorderalcohol use disorder
โ†’
46.
Collaborative Care Model Implementation
intermediatecollaborative careIMPACT trialprimary care integration
โ†’
47.
Evaluating ECT Outcomes for Treatment-Resistant Depression
hardECTelectroconvulsive therapytreatment-resistant depression
โ†’
48.
Assessing Capacity for Informed Consent
harddecisional capacityinformed consentECT
โ†’
49.
Psychotropic Medication Management in Renal Impairment
hardlithiumrenal-impairmentpharmacokinetics
โ†’
50.
Psychiatric Assessment of Deaf and Hard of Hearing Patients
harddeaf-communityASLcommunication-barriers
โ†’
51.
Geriatric Psychosis: Late-Onset Schizophrenia vs. Dementia-Related Psychosis
hardgeriatric-psychosislate-onset-schizophreniadementia
โ†’
52.
Foster Care Youth Psychiatric Assessment and Psychotropic Oversight
hardfoster-carepolypharmacycomplex-trauma
โ†’
53.
Psychiatric Assessment Following Traumatic Brain Injury
hardtraumatic-brain-injuryneuropsychiatryfrontal-lobe
โ†’
54.
Refugee and Asylum Seeker Mental Health Assessment
hardrefugeeasylum-seekercultural-competence
โ†’
55.
Psychiatric Considerations in HIV/AIDS and Antiretroviral Interactions
hardHIV-AIDSdrug-interactionsCYP3A4
โ†’
56.
Behavioral Assessment in Intellectual Disability
intermediateintellectual-disabilitydental-painself-injurious-behavior
โ†’
57.
Severe Bipolar Disorder in Pregnancy: Risk-Benefit Assessment
hardpregnancybipolar-disorderlithium
โ†’
58.
Adolescent Transgender Patient: Gender-Affirming Mental Health Assessment
hardtransgenderadolescentgender-dysphoria
โ†’
59.
Geriatric Benzodiazepine Deprescribing Assessment
intermediategeriatricbenzodiazepine-deprescribingfalls
โ†’
60.
Co-occurring Autism and Anxiety in Adults: Assessment Differentiation
hardautism-spectrum-disorderanxietyOCD
โ†’
61.
Treatment Planning for Comorbid Generalized Anxiety Disorder and Insomnia
hardgeneralized anxiety disorderinsomniacomorbidity
โ†’
62.
Planning Stepped-Care Model for Depression
hardstepped caredepressiontreatment planning
โ†’
63.
Measurement-Based Care Implementation Using Standardized Outcome Tracking
hardmeasurement-based carePHQ-9treatment response
โ†’
64.
Motivational Interviewing to Address Medication Adherence Ambivalence
hardmotivational interviewingmedication adherencebipolar disorder
โ†’
65.
Risk Management Documentation in Outpatient Psychiatric Practice
hardrisk managementsuicide assessmentdocumentation
โ†’
66.
Patient Safety and Medication Error Prevention Strategies
hardpatient safetymedication errorssystems-based practice
โ†’
67.
Health Literacy Assessment in Psychiatric Medication Education
hardhealth literacyteach-back methodmedication education
โ†’
68.
Therapeutic Communication Techniques With an Angry Patient
hardtherapeutic communicationde-escalationPTSD
โ†’
69.
Trauma-Informed Organizational Practices to Prevent Retraumatization
hardtrauma-informed careorganizational practicesretraumatization prevention
โ†’
70.
Substance Use Harm Reduction Approaches in Outpatient Practice
hardharm reductionopioid use disordernaloxone
โ†’
71.
Geriatric Psychopharmacology and Reduced Hepatic Clearance
hardgeriatric-pharmacologyhepatic-metabolismphase-I-phase-II
โ†’
72.
School Refusal in Pediatric Anxiety: Intervention Planning
hardschool-refusalpediatric-anxietyseparation-anxiety
โ†’
73.
Lamotrigine Dose Adjustments During Pregnancy
hardlamotriginepregnancyUGT1A4
โ†’
74.
Psychiatric Care Barriers in Incarcerated Populations
hardincarcerated-populationsforensic-psychiatrymedication-discontinuation
โ†’
75.
Medication Management Challenges in Homeless Populations
hardhomelessnessmedication-adherencelong-acting-injectable
โ†’
76.
Sundown Syndrome Assessment in Elderly Patients
hardsundowningdementiaAlzheimer-disease
โ†’
77.
Social Media Impact on Adolescent Mental Health
hardsocial-mediaadolescent-mental-healthbody-image
โ†’
78.
Rural Telehealth Psychiatric Care Delivery
hardtelepsychiatryrural-mental-healthcollaborative-care
โ†’
79.
Minority Stress Model in LGBTQ+ Youth Assessment
hardminority-stressLGBTQ-youthtransgender
โ†’
80.
Chronic Pain and Psychiatric Comorbidity in Elderly Patients
hardchronic-paingeriatric-depressionsuicide-risk
โ†’
81.
Acculturative Stress in First-Generation Immigrants
hardacculturative-stressimmigrationcultural-formulation
โ†’
82.
Concussion and Psychiatric Sequelae in Athletes
hardconcussionsports-psychiatrypost-concussion-syndrome
โ†’
83.
Evaluating Response to CBT Augmentation for Treatment-Resistant OCD
hardOCDexposure and response preventionY-BOCS
โ†’
84.
Evaluating Response to Integrated Dual-Diagnosis Treatment
harddual diagnosisbipolar II disorderalcohol use disorder
โ†’
85.
Evaluating Pediatric SSRI Response Using Validated Measures
hardpediatric depressionfluoxetineCDRS-R
โ†’
86.
Evaluating Treatment Response in Panic Disorder
hardpanic disorderagoraphobiaPDSS
โ†’
87.
Evaluating Medication Adherence with Urine Drug Testing
hardmedication adherenceurine drug testingschizophrenia
โ†’
88.
Evaluating Treatment Response in Insomnia Using Sleep Diary
hardinsomniaCBT-Isleep diary
โ†’
89.
Evaluating Family Therapy Outcomes in Adolescent Depression
hardadolescent depressionattachment-based family therapyfamily therapy
โ†’
90.
Planning Integrated Primary Care and Behavioral Health
hardcollaborative careintegrated careFQHC
โ†’
91.
Planning Discharge and Transition of Care
harddischarge planningtransition of carelong-acting injectable
โ†’
92.
Planning Medication Adjustment for Renal Impairment
hardlithium nephropathyrenal impairmentmood stabilizer
โ†’
93.
Planning Trauma-Focused Treatment Sequencing
hardcomplex PTSDtrauma treatmentphased model
โ†’
94.
Evaluating Polypharmacy Reduction Outcomes
hardpolypharmacydeprescribingakathisia
โ†’
95.
Evaluating Long-Term Antidepressant Continuation Criteria
hardantidepressant maintenancerecurrent depressioncontinuation criteria
โ†’
96.
Evaluating Treatment Response in ARFID
moderateARFIDfeeding disordertreatment response
โ†’
97.
Pediatric ADHD Comprehensive Assessment
intermediateADHDpediatric assessmentVanderbilt scales
โ†’
98.
Pediatric ADHD Medication Management and Stimulant Selection
intermediateADHDstimulant medicationsmethylphenidate
โ†’
99.
Geriatric Depression with Comorbid Cognitive Decline Differential Diagnosis
hardgeriatric depressionpseudodementiacognitive decline
โ†’
100.
Geriatric Depression SSRI Management and Safety Considerations
hardgeriatric depressionSSRI managementdrug interactions
โ†’
101.
Pregnancy Psychopharmacology SSRI Risk-Benefit Analysis
hardpregnancypsychopharmacologysertraline
โ†’
102.
Lactation Psychopharmacology and Medication Selection
intermediatepostpartum depressionlactationbreastfeeding
โ†’
103.
Adolescent Self-Harm Assessment and Risk Stratification
hardadolescentself-harmNSSI
โ†’
104.
Adolescent Self-Harm Safety Planning and Family Intervention
hardadolescentself-harmsafety planning
โ†’
105.
Geriatric Alcohol Use Disorder Screening and Treatment Initiation
hardgeriatricalcohol use disordermotivational interviewing
โ†’
106.
Geriatric Benzodiazepine Use Disorder and Deprescribing
hardgeriatricbenzodiazepinedeprescribing
โ†’
107.
Autism Spectrum Disorder with Comorbid Anxiety in a Child
intermediateautism spectrum disorderASDanxiety
โ†’
108.
ASD Adolescent Irritability and Aggression Pharmacological Management
intermediateautism spectrum disorderASDirritability
โ†’

Other AANPCB knowledge areas

๐Ÿงฌ Scientific Foundations๐Ÿ’Š Pharmacologyโšก Nonpharmacological Therapies๐Ÿ—ฃ๏ธ Psychotherapies๐Ÿ” Assessment & Diagnosis๐Ÿ“Œ Professional Role
โ† AANPCB Board Prep